MedTrace Logo

Evaluation the Effect of Coenzyme Q10 on Tissue Healing Process in Patients Undergoing Wisdom Tooth Extraction

NCT06452134 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-06-11

No results posted yet for this study

Summary

The goal of this clinical trial is to asses the effect of Coenzyme Q10 administration in patients from any gender group who are older than 18 years old undergoing wisdom tooth extraction. The main questions it aims to answer are:

does Coenzyme Q10 help with better tissue healing? does Coenzyme Q10 administration lower the prevalence of Dry socket after surgery? does Coenzyme Q10 prevent TMD (Temporomandibular disorders) while recovering from surgery? how does Coenzyme Q10 administration effect the answers to SF-36 health survey in patients? Researchers will compare Coenzyme Q10 to a placebo (a look-alike substance that contains no drug) to see if it has any effect on mentioned parameters.

Participants will:

* take coenzyme Q10 (100mg) daily for 30 days after surgery.
* will be examined and evaluated 1, 7, 14 and 30 days after completion of surgery.

Conditions

  • Molar, Third
  • Temporomandibular Joint Disorders
  • Dry Socket
  • Coenzyme Q10

Interventions

DRUG

Coenzyme Q10 100 MG Oral Tablet

Coenzyme Q10 oral Tablet with dosage of 100mg daily given for a period of 30 days after surgery.

DRUG

Placebo

Exactly same looking agent in the form of a tablet with same size and color to CoezymeQ10 with no active property given for a period of 30 days after surgery.

Sponsors & Collaborators

  • Kurdistan University of Medical Sciences

    collaborator OTHER

  • Hady Mohammadi, Director of oral and maxillofacial surgery department, school of dentistry, Kurdistan university of medical sciences

    collaborator UNKNOWN

  • Yousef Moradi, Assistant professor, Department of epidemiology and biostatistics, Kurdistan university of medical sciences

    collaborator UNKNOWN

  • Babak Ghadirzadeh, medical student, Kurdistan university of medical sciences

    collaborator UNKNOWN

  • Zahra Nejati

    lead OTHER

Principal Investigators

  • Zahra Nejati · Zahra Nejati, Department of oral and maxillofacial medicine, School of Dentistry, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2024-09-30
Completion
2025-05-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06452134 on ClinicalTrials.gov